EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso — EFECAB

Cysticercosis Clinical Trial

Official title:
EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso

Status Completed

Clinical Trial Summary

This is a pre-post randomized community-based controlled trial aimed at estimating the effectiveness of an educational package developed using PRECEDE PROCEED to reduce the cumulative incidence of Taenia solium cysticercosis in three Provinces of Burkina Faso. The study design included an 18-months baseline study to measure baseline cumulative incidence of cysticercosis followed by an 18-month post randomization study to measure the effectiveness of the intervention. Sixty villages of three Provinces of Burkina Faso were included. The primary outcome was the change in the baseline to post randomization cumulative incidence in the intervention group compared to the control group.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03095339
Study type	Interventional
Source	University of Oklahoma
Contact
Status	Completed
Phase	N/A
Start date	February 21, 2011
Completion date	January 31, 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00001205` - Natural History of Treated Neurocysticercosis and Long-Term Outcomes
Completed	`NCT05010811` - Two Cases of Pulmonary Cysticercosis Manifesting as Pleural Effusion: Case Report and Literature Review
Completed	`NCT00004403` - Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis	N/A
Completed	`NCT00001912` - Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis	N/A
Completed	`NCT01368354` - Taenia Solium Control Case Study in Zambia	N/A
Completed	`NCT03808597` - Digital Health Promotion in Iringa, Tanzania	N/A